We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$661M
AUM Growth
-$473M
Cap. Flow
-$486M
Cap. Flow %
-73.58%
Top 10 Hldgs %
6.77%
Holding
1,175
New
248
Increased
83
Reduced
484
Closed
358

Top Buys

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$3.58M
2
AZO icon
AutoZone
AZO
+$3.03M
3
HWM icon
Howmet Aerospace
HWM
+$2.87M
4
ANSS
Ansys
ANSS
+$2.84M
5
IT icon
Gartner
IT
+$2.66M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.61M
2
GM icon
General Motors
GM
+$6.29M
3
BG icon
Bunge Global
BG
+$5.38M
4
QCOM icon
Qualcomm
QCOM
+$5M
5
USFD icon
US Foods
USFD
+$4.97M

Sector Composition

Rank Sector Weight
1 Technology 21.14%
2 Healthcare 20.5%
3 Financials 14.07%
4 Industrials 12.62%
5 Consumer Discretionary 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CME icon
1
CME Group
CME
$92.2B
$11.3M 1.71%
63,800
-3,800
-6% -$751K
ALB icon
2
Albemarle
ALB
$13.5B
$4.73M 0.72%
17,887
-2,533
-12% -$644K
TTEK icon
3
Tetra Tech
TTEK
$8.23B
$3.84M 0.58%
149,520
-42,540
-22% -$1.19M
AGL icon
4
Agilon Health
AGL
$1.64B
$3.7M 0.56%
6,320
-2,712
-30% -$1.62M
ENPH icon
5
Enphase Energy
ENPH
$4.84B
$3.64M 0.55%
13,126
+6,337
+93% +$1.71M
ZS icon
6
Zscaler
ZS
$23B
$3.59M 0.54%
21,829
-13,099
-38% -$2.14M
PTCT icon
7
PTC Therapeutics
PTCT
$6.37B
$3.54M 0.54%
70,579
-26,452
-27% -$1.3M
AZO icon
8
AutoZone
AZO
$48.3B
$3.5M 0.53%
1,635
+1,390
+567% +$3.03M
CPNG icon
9
Coupang
CPNG
$27.8B
$3.45M 0.52%
+207,142
New +$3.58M
CSIQ icon
10
Canadian Solar
CSIQ
$906M
$3.43M 0.52%
92,092
-52,181
-36% -$1.99M
MASI
11
DELISTED
Masimo
MASI
$3.31M 0.5%
23,469
-29,076
-55% -$4.25M
FTI icon
12
TechnipFMC
FTI
$30.6B
$3.3M 0.5%
390,249
-238,376
-38% -$1.88M
ATI icon
13
ATI
ATI
$27B
$3.27M 0.49%
122,814
-36,753
-23% -$1.02M
SNPS icon
14
Synopsys
SNPS
$71.5B
$3.24M 0.49%
10,615
-432
-4% -$146K
HON icon
15
Honeywell
HON
$77.1B
$3.17M 0.48%
20,159
-13,815
-41% -$2.41M
ATKR icon
16
Atkore
ATKR
$2.59B
$3.17M 0.48%
40,747
-26,305
-39% -$2.27M
BC icon
17
Brunswick
BC
$5.19B
$3.13M 0.47%
47,883
-44,589
-48% -$3.35M
AVT icon
18
Avnet
AVT
$7.33B
$3.12M 0.47%
86,249
-45,087
-34% -$1.94M
ADP icon
19
Automatic Data Processing
ADP
$100B
$3.06M 0.46%
13,550
-7,667
-36% -$1.81M
LII icon
20
Lennox International
LII
$18.8B
$3.03M 0.46%
13,626
-6,257
-31% -$1.49M
ANET icon
21
Arista Networks
ANET
$219B
$3.02M 0.46%
106,864
-155,200
-59% -$4.48M
EVH icon
22
Evolent Health
EVH
$475M
$2.97M 0.45%
82,740
+27,039
+49% +$953K
CDNS icon
23
Cadence Design Systems
CDNS
$90B
$2.95M 0.45%
18,069
-8,736
-33% -$1.5M
ALKS icon
24
Alkermes
ALKS
$8.82B
$2.9M 0.44%
129,899
-53,047
-29% -$1.38M
CACC icon
25
Credit Acceptance
CACC
$6B
$2.87M 0.43%
6,554
-3,188
-33% -$1.68M

Similar funds

PDT Partners's Q3 2022 Portfolio in Review

As of Q3 2022, PDT Partners held 1,175 positions worth $661M, down 42% from $1.13B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

PDT Partners withdrew a net $486M in Q3 2022, closing 358 positions and reducing 484 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $7.61M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, PDT Partners opened a new position in Coupang worth $3.45M.

  • PDT Partners's largest Q3 2022 buy was Coupang: 207,142 shares worth $3.45M.
  • PDT Partners added most to AutoZone in Q3 2022, an estimated $3.03M increase.
  • PDT Partners's biggest Q3 2022 reduction was General Motors, cutting an estimated $6.29M.
  • PDT Partners fully exited Vertex Pharmaceuticals in Q3 2022, selling an estimated $7.61M.
  • PDT Partners's ten largest holdings make up 6.8% of its $661M portfolio in Q3 2022.
  • PDT Partners opened 248 new positions and closed 358 in Q3 2022.
  • PDT Partners's portfolio value fell 42% quarter-over-quarter to $661M.

Based on PDT Partners's 13F filing for Q3 2022, filed 14 Nov 2022.